BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 605351)

  • 21. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The HB antigen system in chronic liver diseases].
    Loginov AS; Tsaregorodtseva TM; Zotina MM; Serova TI; Tkachev VD
    Ter Arkh; 1983; 55(1):107-12. PubMed ID: 6836515
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.
    Lee WM; Reed WD; Mitchell CG; Galbraith RM; Eddleston AL; Zuckerman AJ; Williams R
    Br Med J; 1975 Mar; 1(5960):705-8. PubMed ID: 1125673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating immune complexes and cell-mediated immunity in patients with hepatitis B virus associated liver diseases.
    Kim SA; Lee SI; Choi IH; Shin JS; Uhm JR; Kim SJ; Choi HJ
    Yonsei Med J; 1990 Dec; 31(4):347-58. PubMed ID: 2150250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of antibody formation to HBsAg in the pathogenesis of chronic hepatitis and cirrhosis?
    Schlicht I; Gadow J; Ortmans H; Jorno L; Gentz HD; Wolter G; Hoppe I
    Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):450-6. PubMed ID: 549426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delayed hypersensitivity to the surface antigen of the hepatitis B virus].
    Titov MB; Gersun BA; Shevchenko LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jul; (7):82-5. PubMed ID: 7124212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Test of leukocyte migration in agarose (LMAT) in HBs positive and negative chronic hepatopathies in the presence of an HBsAg preparation].
    Craxi A; Genova G; Spano C; Chiarini A; Pagliaro L
    Minerva Gastroenterol; 1976; 22(3):253-6. PubMed ID: 1004759
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection, by three techniques, of hepatitis B surface antigen (HBsAg) and determination of HBsAg and anti-HBs titres in patients with chronic liver disease.
    Chiaramonte M; Heathcote J; Crees M; Sherlock S
    Gut; 1977 Jan; 18(1):1-6. PubMed ID: 838398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and humoral immunity in viral hepatitis.
    Lee WM
    Am J Clin Pathol; 1976 May; 65(5 Suppl):866-9. PubMed ID: 85410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leucocyte migration inhibition in liver disease.
    Vergani C; Oldoni T; Dioguardi N
    J Clin Pathol; 1974 Oct; 27(10):772-5. PubMed ID: 4610006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgM responses to hepatitis-A virus and hepatitis-B core antigen in acute and chronic liver disease in Malawi; possible role of non-A, non-B, hepatitis.
    Supran EM; Molyneux ME; Banatvala JE
    Trans R Soc Trop Med Hyg; 1980; 74(3):389-92. PubMed ID: 6254219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific immunotherapy proposed for hepatitis B virus infection.
    Vyas GN; Schmid R; Ibrahim AB; Rao KR
    Dev Biol Stand; 1975; 30():350-6. PubMed ID: 1204970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.
    Lee WM; Reed WD; Osman CG; Vahrman J; Zuckerman AJ; Eddleston AL; Williams R
    Gut; 1977 Mar; 18(3):250-7. PubMed ID: 856683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver.
    Kojima M; Udo K; Takahashi Y; Yoshizawa H; Tsuda F; Itoh Y; Miyakawa Y; Mayumi M
    Gastroenterology; 1977 Oct; 73(4 Pt 1):664-7. PubMed ID: 330306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection.
    Helmy A; Al-Sebayel MI
    World J Gastroenterol; 2006 Jul; 12(27):4406-10. PubMed ID: 16865787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioimmunoquantization of the HBAg in clinical liver diseases].
    De Ritis F; Gravina E; Squame G; Celentano L
    Quad Sclavo Diagn; 1975 Jun; 11(2):446-62. PubMed ID: 1223948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leucocyte migration inhibition with inner and outer membranes of mitochondria and insoluble hepatocyte surface membranes prepared from rat liver in patients with chronic hepatitis and cirrhosis.
    Ohta G; Nonomura A; Nishimura I
    Clin Exp Immunol; 1976 Dec; 26(3):491-504. PubMed ID: 1009683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.